Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
IN8bio, Inc. (INAB) had Income from Continuous Operations of $-19.44M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-19.44M |
|
-- |
|
-- |
|
$19.86M |
|
$-19.86M |
|
$0.42M |
|
$-19.44M |
|
$-19.44M |
|
$-19.44M |
|
|
Income from Continuous Operations |
$-19.44M |
$-19.44M |
|
$-19.44M |
|
$-19.86M |
|
$-17.36M |
|
4.37M |
|
4.37M |
|
$-4.44 |
|
$-4.44 |
|
| Balance Sheet Financials | |
$27.88M |
|
$1.86M |
|
$4.40M |
|
$32.28M |
|
$3.16M |
|
-- |
|
$1.56M |
|
$4.72M |
|
$27.56M |
|
$27.56M |
|
$27.56M |
|
9.77M |
|
| Cash Flow Statement Financials | |
$-12.71M |
|
-- |
|
$28.64M |
|
$11.39M |
|
$27.31M |
|
$15.93M |
|
$3.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.82 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-70.54% |
|
-70.54% |
|
-60.22% |
|
-70.54% |
|
$2.82 |
|
$-2.91 |
|
$-2.91 |
|